ML-based frameworks for WSI IHC analysis are being developed for the automated detection of BRCA1-Associated Protein 1 (BAP1) loss, which has retrospectively been associated with higher tumour grade, increased metastatic potential, and poorer clinical outcomes in clear cell RCCs [113]. This evidence concerns the gene BAP1 and neoplasm.